Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Petrelintide in Overweight/Obesity and Type 2 Diabetes
NCT06926842Phase 2Completed
- Sponsor
- Zealand Pharma
- Start
- Apr 2025
- Primary completion
- Aug 2026
- Modality
- Hormonal Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of petrelintide in obesity, type 2 diabetes mellitus (T2DM), sponsored by Zealand Pharma. Started Apr 2025; status: completed.
02
Drugs
03
Conditions
obesitytype 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT06926842.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06926842.